Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in ZVRA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,129,775
-$2,071,414 QoQ
Shares Held
443,109
-36.0% QoQ
Ownership
0.750%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Derivatives in ZVRA

reported options exposure · as of Mar 31, 2026
CallValue
$1,236,764
CallShares
132,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $333,275,952 across 117 Biotechnology names. ZVRA ranks #18 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZVRA

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,129,775 443,109
2026-03-31 $1,236,764 132,700
2025-12-31 $1,026,816 114,600
2025-12-31 $6,201,189 692,097
2025-09-30 $388,008 40,800
2025-09-30 $4,259,490 447,896